| α-SMA |
alpha smooth muscle actin |
| ABCC |
ATP-binding cassette subfamily C member |
| ADP |
adenosine diphosphate |
| AGE |
advanced glycation end products |
| Akt |
protein kinase B |
| ALK |
activin like kinase |
| APA |
antiplatelet antibodies |
| ARNT |
Aryl hydrocarbon receptor nuclear translocator or HIF-1β |
| ATP |
adenosine triphosphate |
| BCL-2 |
B cell lymphoma-2 |
| BMP |
bone morphogenetic protein |
| BRCA |
breast cancer susceptibility gene |
| CAF |
cancer associated fibroblast |
| CAPD |
continuous ambulatory peritoneal dialysis |
| CCL5 |
chemokine (C-C motif) ligand 5 |
| CCN |
Cysteine-rich 61, Connective tissue growth factor, Nephroblastoma overexpressed |
| CD |
cluster of differentiation |
| CDH1 |
E-cadherin gene |
| CDK |
cyclin dependent kinase |
| CLEC-2 |
C-type lectin-like receptor 2 |
| COX |
cyclo-oxygenase |
| CRC |
colorectal cancer |
| CRS |
cytoreductive surgery |
| CSC |
cancer stem cell |
| CTGF |
connective tissue growth factor, CCN2 |
| CXCL |
C-X-C chemokine ligand |
| CXCR4 |
C-X-C chemokine receptor type 4 |
| DAMP |
damage-associated molecular pattern |
| ECM |
extracellular matrix |
| EGFR |
epidermal growth factor receptor |
| EM |
endometriosis |
| EMT |
epithelial mesenchymal transition |
| EPS |
encapsulating peritoneal sclerosis |
| ER-α |
estrogen receptor alpha |
| ERE |
estrogen response element |
| ERK |
extracellular signal-regulated kinase |
| FAK |
focal adhesion kinase |
| FGF |
fibroblast growth factor |
| FSP-1 |
fibroblast specific protein-1 |
| GDP |
glucose degradation products |
| GITR |
glucocorticoid-induced tumor necrosis factor receptor-related |
| GLUT |
membrane glucose transporter |
| GPR30 |
G protein coupled estrogen receptor 30 (GPER) |
| HA |
hyaluronan |
| HER2 |
human epidermal growth factor |
| HGF |
hepatocyte growth factor |
| HIF |
hypoxia inducible factor |
| HIPEC |
hyperthermic intraperitoneal chemotherapy |
| HMGB1 |
high-mobility group box 1 protein |
| HRE |
hypoxia response element |
| HSP |
heat shock protein |
| IFN |
interferon |
| IGF-1 |
insulin-like growth factor-1 |
| IL |
interleukin |
| ILK |
integrin linked kinase |
| JNK |
c-Jun N-terminal kinase |
| KRAS |
Kirsten rat sarcoma virus oncogene |
| LDHA |
Lactate dehydrogenase A |
| LMW |
low molecular weight |
| MAP3K |
mitogen-activating protein kinase kinase kinase |
| MDRT |
multidrug resistance transporter |
| MHC |
major histocompatibility complex |
| miRNA |
microRNA |
| MMP |
matrix metalloprotease |
| MMT |
mesothelial mesenchymal transition |
| mRNA |
messenger ribonucleic acid |
| mTOR |
mammalian target of rapamycin |
| MYD88 |
myeloid differentiation factor 88 |
| NF-E2 |
nuclear factor erythroid-derived 2, Nrf2 |
| NF-κB |
nuclear factor kappa light chain enhancer of activated B cells |
| NK |
natural killer |
| NOD |
nucleotide-binding oligomerization domain |
| NOV |
nephroblastoma overexpressed gene |
| PAI-1 |
plasminogen activator inhibitor-1 |
| PAMP |
pathogen-associated molecular pattern |
| PARP |
Poly (ADP-ribose) polymerase |
| PDF |
peritoneal dialysis fluid |
| p53 |
tumor suppressor protein 53 |
| PDGF |
platelet derived growth factor |
| PHD |
prolyl hydroxylase |
| PI3K |
phosphoinositide 3-kinase |
| PK |
pyruvate kinase |
| PKM2 |
pyruvate kinase isoenzyme M2 |
| PLCγ2 |
phospholipase C gamma 2 |
| PM |
peritoneal metastasis |
| PMC |
peritoneal mesothelial cell |
| PPAR |
peroxisome proliferator activated receptor |
| PPF |
proplatelet formation |
| PRRX-1 |
Paired Related Homeobox 1 |
| RAGE |
receptor for advanced glycosylation end products |
| ROCK |
rho-associated, coiled-coil-containing protein kinase |
| ROS |
reactive oxygen species |
| RTK |
receptor tyrosine kinase |
| SERD |
selective estrogen receptor degrader |
| SERM |
selective estrogen receptor modulator |
| SLUG |
Zinc finger protein SNAI2 |
| SMAD |
Small body +mothers against decapentaplegic |
| SOD |
Superoxide dismutase |
| SNAIL |
Zinc finger protein SNAI1 |
| Src |
non receptor sarcoma tyrosine kinase |
| SRC |
steroid receptor coactivator |
| Sp-1 |
specificity protein 1 |
| STAT3 |
signal transducer and activator of transcription |
| TAK-1 |
TGF-β-activated kinase 1 or MAP3K7 |
| TAM |
tumor (tissue) associated macrophages |
| TβR |
transforming growth factor beta receptor |
| TF |
tissue factor |
| TGF-β1 |
transforming growth factor-β1 |
| Th |
T helper |
| TKI |
tyrosine kinase inhibitor |
| TIMP |
tissue inhibitor of metalloproteases |
| TLR2 |
toll-like receptor |
| TME |
tumor microenvironment |
| TNF-α |
tumor necrosis factor alpha |
| TPO |
thrombopoietin |
| tPA |
tissue plasminogen activator |
| TRAF6 |
TNF receptor associated factor |
| Tregs |
regulatory T cells |
| TWIST1 |
twist basic helix loop helix transcription factor 1 |
| VEGF |
vascular endothelial growth factor |
| VTE |
venous thromboembolism |